» Articles » PMID: 21529907

Polymorphism of the Pre-miR-146a is Associated with Risk of Cervical Cancer in a Chinese Population

Overview
Journal Gynecol Oncol
Date 2011 May 3
PMID 21529907
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: MicroRNAs are tiny non-coding RNAs that reportedly play an important role in numerous physiological processes. A G>C polymorphism (rs2910164) is located on the passenger strand of the precursor of miR-146a, which could alter mature miR-146a expression. We hypothesized that a possible association exists between miR-146a gene polymorphisms and cervical cancer risk in a population-based control study of female residents in Jiangsu Province.

Methods: The subjects included 447 cervical cancer cases and 443 cancer-free controls with frequency matched by age. We genotyped the functional polymorphism of miR-146a (rs2910164) by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method, and used a sample of 24 cervical cancer tissue to test the expression of miR-146a by real-time quantitative reverse transcription.

Results: Our study indicated that the subjects carrying GG homozygote had a 1.496-fold increased risk than those carrying CG/CC genotypes (95% CI=1.068-2.095). Moreover, miR-146a quantification showed that the carriers of GG genotype had obviously more reduced miR-146a expression level compared with the carriers of CC genotype.

Conclusion: Our study suggests that the risk of cervical cancer in a Chinese population partly results from miRNA-146a expression deviation in vivo, being caused by common polymorphism in miR-146a. This is an initial study to indicate that miR-146a (rs2910164) might contribute to cervical cancer susceptibility.

Citing Articles

MicroRNA-146: Biomarker and Mediator of Cardiovascular Disease.

Mahdavi F, Mardi S, Mohammadi S, Ansari S, Yaslianifard S, Fallah P Dis Markers. 2024; 2022:7767598.

PMID: 39281713 PMC: 11401689. DOI: 10.1155/2022/7767598.


The genetic variant HLA-DQB1 is associated with a protective effect against cervical cancer.

Vinokurov M, Mironov K, Domonova E, Romanyuk T, Popova A, Akimkin V Front Oncol. 2023; 13:1207935.

PMID: 37614503 PMC: 10443639. DOI: 10.3389/fonc.2023.1207935.


Consequences of genetic variants in miRNA genes.

Machowska M, Galka-Marciniak P, Kozlowski P Comput Struct Biotechnol J. 2022; 20:6443-6457.

PMID: 36467588 PMC: 9708458. DOI: 10.1016/j.csbj.2022.11.036.


Association of Polymorphisms in , an Inflammation-Associated MicroRNA, with the Risk of Idiopathic Recurrent Spontaneous Miscarriage: A Case-Control Study.

Salimi S, Sargazi S, Mollashahi B, Heidari Nia M, Mirinejad S, Majidpour M Dis Markers. 2022; 2022:1495082.

PMID: 35535334 PMC: 9078850. DOI: 10.1155/2022/1495082.


Association of three micro-RNA gene polymorphisms with the risk of cervical cancer: a meta-analysis and systematic review.

Xu J, Geng J, Zhang Q, Fan Y, Qi Z, Xia T World J Surg Oncol. 2021; 19(1):346.

PMID: 34911543 PMC: 8675500. DOI: 10.1186/s12957-021-02463-4.